News
Novo Nordisk, the Danish maker of the wildly popular Ozempic and Wegovy drugs used for weight loss, was downgraded due to ...
InvestorsHub on MSN26m
Hims and Hers shares drop after revenue falls short amid GLP-1 scrutinyShares of Hims and Hers Health (NYSE:HIMS) slid 14% in premarket trading following the telehealth company’s announcement of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback